Carl L Gordon bought $20.0M of Electra Therapeutics (ETRA)

Executed Sep 21, disclosed Sep 23, 2 days later.

Value, as filed

$20.0M

1,333,333 sh across 2 lots

Executed

Sep 21

the trade date, as filed

Disclosed

Sep 23

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer

CG Carl L Gordon Director profile →

Carl L Gordon (Director) filed 3 Form 4 reports in the trailing twelve months (3 purchases, 0 sales), most often in BlossomHill Therapeutics, Inc. Common Stock (BLSM). Across 2 priced purchase filings, the average 21-session return was +56.2% from execution and +52.9% from disclosure (delay-adjusted; derived). The largest single filing was $20.0M of ETRA (1,333,333 sh across 2 lots, as filed), executed Sep 21.

The name

ETRA

Electra Therapeutics, Inc. ETRA · Healthcare · 2 filings in 24 months ticker →

Healthcare · Electra Therapeutics, Inc. is a clinical-stage biotechnology company

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→